Hyderabad, Feb.17 (RAHNUMA): Chief Minister A. Revanth Reddy, along with Minister D. Sridhar Babu, met top executives and representatives of several global life sciences companies on the sidelines of BioAsia 2026 on Tuesday.
The Chief Minister reiterated that the state government is committed to providing all necessary support for companies looking to invest in Hyderabad. He said several leading life sciences companies have established global capability centres (GCCs) in Hyderabad.
To build on this, the Chief Minister proposed to build a dedicated zone for GCCs in Bharat Future City, with special emphasis on facilitating innovation centres for global life sciences companies.
Details of investments announced that Opella Healthcare, a global consumer healthcare company, spun off from Sanofi, with its global headquarters in France, is expanding its GCC operations in a 42,000 sq. ft. facility, creating up to 500 jobs within the next year.
Similarly, the Vaksindo Animal Health Pvt Ltd, a division of JAPFA Indonesia, is establishing a state-ofthe-art BSL-3 vaccine manufacturing facility in Genome Valley. The facility will focus on producing vaccines for poultry, cattle, swine, and aquaculture.
The Tredence Inc, an AI and data science company, is announcing its Hyderabad operations as a dedicated innovation hub focused on AI-driven healthcare and life sciences analytics. The facility will span approximately 18,000 sq. ft. and support its global operations.
In addition to this, Rx Propellant (RxP) will develop a new, large-format life sciences campus in Genome Valley, Hyderabad as part of its long-term commitment to strengthening India’s life sciences ecosystem. The project will comprise over 1 million square feet of advanced laboratory infrastructure spread across nearly 12 acres of site delivered in phases over the next six years.
